Hongqing Zhou

Qujing, 655000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.

Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.

Journal: Expert opinion on investigational drugs
Published: August 19, 2026

Multimodal cell death-associated inflammatory niches recruit but spatially constrain GZMB+ cytotoxic T lymphocytes in glioblastoma.

Multimodal cell death-associated inflammatory niches recruit but spatially constrain GZMB+ cytotoxic T lymphocytes in glioblastoma.

Journal: Clinical immunology (Orlando, Fla.)
Published: March 18, 2026

Environmental benzophenone exposure promotes liver cancer cell proliferation via the IRE1α-XBP1s pathway.

Environmental benzophenone exposure promotes liver cancer cell proliferation via the IRE1α-XBP1s pathway.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: January 14, 2026

Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation.

Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation.

Journal: Precision clinical medicine
Published: January 03, 2026

Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression.

Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression.

Journal: EBioMedicine
Published: April 24, 2024

Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis.

Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis.

Journal: Journal of Cancer
Published: March 15, 2024

Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.

Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.

Journal: Nature communications
Published: March 06, 2024

The SDF-1/CXCR4 axis is involved in adipose-derived stem cell migration.

The SDF-1/CXCR4 axis is involved in adipose-derived stem cell migration.

Journal: Neurourology and urodynamics
Published: December 06, 2023

Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression.

Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression.

Journal: Theranostics
Published: November 17, 2023

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.

Journal: BMC medicine
Published: March 27, 2023

Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells.

Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells.

Journal: Frontiers in oncology
Published: August 30, 2022

IDO promotes the proliferation and invasion of prostate cancer cells through KYNU.

IDO promotes the proliferation and invasion of prostate cancer cells through KYNU.

Journal: Genes & genomics
Published: June 12, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026